138 related articles for article (PubMed ID: 15921676)
1. Stimulatory effects of eicosanoids on ovarian angiogenesis in early luteal phase in cyclooxygenase-2 inhibitor-treated rats.
Sakurai T; Tamura K; Kogo H
Eur J Pharmacol; 2005 Jun; 516(2):158-64. PubMed ID: 15921676
[TBL] [Abstract][Full Text] [Related]
2. Possible role of cyclooxygenase II in the acquisition of ovarian luteal function in rodents.
Sakurai T; Tamura K; Okamoto S; Hara T; Kogo H
Biol Reprod; 2003 Sep; 69(3):835-42. PubMed ID: 12724285
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
Ghosh AK; Hirasawa N; Niki H; Ohuchi K
J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor increases messenger RNAs encoding cyclooxygenase-II and membrane-associated prostaglandin E synthase in rat luteal cells.
Sakurai T; Tamura K; Kogo H
J Endocrinol; 2004 Dec; 183(3):527-33. PubMed ID: 15590979
[TBL] [Abstract][Full Text] [Related]
5. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
[TBL] [Abstract][Full Text] [Related]
6. Role of vascular endothelial growth factor in ovarian physiology - an overview.
Kaczmarek MM; Schams D; Ziecik AJ
Reprod Biol; 2005 Jul; 5(2):111-36. PubMed ID: 16100562
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor.
Sánchez-Fidalgo S; Martín-Lacave I; Illanes M; Motilva V
Eur J Pharmacol; 2004 Nov; 505(1-3):187-94. PubMed ID: 15556152
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of tube formation mediated through the prostaglandin EP2 receptor in rat luteal endothelial cells.
Sakurai T; Suzuki K; Yoshie M; Hashimoto K; Tachikawa E; Tamura K
J Endocrinol; 2011 Apr; 209(1):33-43. PubMed ID: 21273371
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants.
Fu YG; Sung JJ; Wu KC; Wu HP; Yu J; Chan M; Chan VY; Chan KK; Fan DM; Leung WK
Cancer Lett; 2005 Jun; 224(2):243-52. PubMed ID: 15914275
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteries.
Hirao A; Kondo K; Takeuchi K; Inui N; Umemura K; Ohashi K; Watanabe H
Cardiovasc Res; 2008 Jul; 79(1):161-8. PubMed ID: 18456673
[TBL] [Abstract][Full Text] [Related]
13. Vascular morphogenesis in the primate ovary.
Fraser HM; Duncan WC
Angiogenesis; 2005; 8(2):101-16. PubMed ID: 16240058
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697).
Churchman A; Baydoun AR; Hoffman R
Eur J Pharmacol; 2007 Nov; 573(1-3):176-83. PubMed ID: 17643408
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of indomethacin and NS-398 (a selective prostaglandin H synthase-2 inhibitor) on implantation in the rat.
Poyser NL
Prostaglandins Leukot Essent Fatty Acids; 1999 Nov; 61(5):297-301. PubMed ID: 10670691
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells.
Bando Y; Noguchi K; Kobayashi H; Yoshida N; Ishikawa I; Izumi Y
J Periodontal Res; 2009 Jun; 44(3):395-401. PubMed ID: 19210337
[TBL] [Abstract][Full Text] [Related]
18. Progestogens stimulate prostacyclin production by human endothelial cells.
Hermenegildo C; Oviedo PJ; García-Martínez MC; García-Pérez MA; Tarín JJ; Cano A
Hum Reprod; 2005 Jun; 20(6):1554-61. PubMed ID: 15734756
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat.
Gaytán M; Bellido C; Morales C; Sánchez-Criado JE; Gaytán F
Reproduction; 2006 Oct; 132(4):571-7. PubMed ID: 17008468
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor Trap suppresses ovarian function at all stages of the luteal phase in the macaque.
Fraser HM; Wilson H; Morris KD; Swanston I; Wiegand SJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5811-8. PubMed ID: 16046580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
